Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
Background Several cancer therapies have been associated with cardiovascular harm in early‐phase clinical trials. However, some cardiovascular harms do not manifest until later‐phase trials. To limit interdisease variability, we focused on breast cancer. Thus, we assessed the reporting of cardiovasc...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wiley
2022-08-01
|
| Rangatū: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Ngā marau: | |
| Urunga tuihono: | https://www.ahajournals.org/doi/10.1161/JAHA.121.025206 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|